NYSE · Healthcare Plans · USD
The Cigna Group (CI) Stock Analysis
The Cigna Group (CI) is a Healthcare Plans stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
CI Key Statistics
As of Oct 21, 2026Trading
- Open
- $305.72
- Previous Close
- $306.60
- Day's Range
- 304.02–306.95
- 52-Week Range
- 239.51–311.34
- Volume
- 1.30M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.30
Valuation
- Market Cap
- $79.88B
- P/E Ratio
- 12.50
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 9.03
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 0.83
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.28
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 24.19
Financials (FY)
- Revenue (FY)
- $273.85B+11.26%
- Net Income (FY)
- $5.96B+73.47%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 2.27%
- Shares Outstanding
- 264.24M
- 1-Year Return
- +1.23%
Dividend and dates
- Dividend
- $6.24+2.06%
- Ex-Dividend Date
- September 8, 2026
- Earnings Date
- November 5, 2026
- Avg Volume
- 1.64M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, CI closed at $304.37, +1.23% over 1 year.
The Cigna Group (CI) has a market capitalization of $79.88B.
In fiscal 2025, CI reported revenue of $273.85B.
CI Stock Return by Calendar Year
The Cigna Group (CI) 10-year return: what $10,000 became
- 1 year
- $10,000 $10,123
- +1.23%
- 5 years
- $10,000 $15,448
- +54.48%
- 10 years
- $10,000 $27,272
- +172.72%
If you had invested $10,000 in The Cigna Group (CI) 10 years ago, at the close on October 21, 2016, it would have been worth $27,272 at the close on October 21, 2026: +172.72% in total, +10.55% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +12.46% |
| 2025 | +1.72% |
| 2024 | −6.27% |
| 2023 | −7.97% |
| 2022 | +46.68% |
| 2021 | +12.29% |
| 2020 | +1.83% |
| 2019 | +7.70% |
| 2018 | −6.46% |
| 2017 | +52.29% |
| 2016 (partial year) | +3.32% |
As of October 21, 2026.
CI Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $273.85B | $5.96B | 2.2% |
| 2024 | $246.15B | $3.43B | 1.4% |
| 2023 | $194.10B | $5.16B | 2.7% |
| 2022 | $179.36B | $6.70B | 3.7% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $273.85B | $24.51B | $8.15B | $5.96B | 2.2% |
| 2024 | $246.15B | $24.99B | $8.44B | $3.43B | 1.4% |
| 2023 | $194.10B | $24.01B | $7.37B | $5.16B | 2.7% |
| 2022 | $179.36B | $22.35B | $7.30B | $6.70B | 3.7% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
CI Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $4.68 | 3 | — |
| 2025 | $6.04 | 4 | +7.9% |
| 2024 | $5.60 | 4 | +13.8% |
| 2023 | $4.92 | 4 | +9.8% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $4.68 | 3 | — |
| 2025 | $6.04 | 4 | +7.9% |
| 2024 | $5.60 | 4 | +13.8% |
| 2023 | $4.92 | 4 | +9.8% |
| 2022 | $4.48 | 4 | +12.0% |
| 2021 | $4.00 | 4 | +9,900.0% |
| 2020 | $0.04 | 1 | +0.0% |
| 2019 | $0.04 | 1 | +0.0% |
| 2018 | $0.04 | 1 | +0.0% |
| 2017 | $0.04 | 1 | — |
Most recent payment: $1.56 per share, ex-dividend September 8, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
CI Valuation vs Healthcare Plans Median
Median of 11 stocks| Metric | CI | Healthcare Plans median | vs median |
|---|---|---|---|
| P/E | 12.50 | 26.38 | 53% below |
| P/S ratio | 0.28 | 0.38 | 26% below |
| Profit margin | 2.27% | 1.18% | 1.1 pts above |
Medians across 11 Healthcare Plans stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Management Raised The Bar For CVS Health Stock; Does The Chart Agree?
Trefis1 Large-Cap Stock to Research Further and 2 We Avoid
YahooUnitedHealth is Down Big Over 3 Months: A Big Bank Says 40% Gains to Come After Raising Their Target
24/7 Wall St.The Cigna Group’s Forward P/E Signals Value. Earnings Risks Remain
YahooWhat You Need to Know Ahead of The Cigna Group’s Earnings Release
BarchartThe Cigna Group's Third Quarter 2026 Earnings Release Details
Yahoo
All 20 articles ↓Show fewer ↑
The Insurance Industry Is Shedding Jobs. It’s Not All About AI.
YahooThe Cigna Group (CI) Analyst/Investor Day Transcript
SeekingAlphaCigna Group (CI), What Is Behind The Fresh Attention?
YahooWednesday's session: gap up and gap down stock in the S&P500 index
ChartMillThe Cigna Group (CI) Analyst/Investor Day - Slideshow
SeekingAlphaThe Cigna Group Hosts 2026 Investor Day; Introduces "Lead to One" to Drive Durable Growth Through Complex Care Leadership and Differentiated Capabilities
YahooMark Cuban Says He’s ‘All for Universal Care’ But Warns It Won’t ‘Automagically Work,’ and the ‘Best First Step’ Is This Warren-Hawley Bill
Barchart‘That’s Immediate Cash in the Bank’: Billionaire Mark Cuban Says the Quickest Way for a Company to Raise Money Is to Change Its PBM
BarchartLiberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Podcast
YahooDid UnitedHealth Name The Fix Before Its Stock Ran?
TrefisShould You Buy CVS Stock For The Margin Aetna Is Rebuilding?
TrefisThe One Cost Line UnitedHealth Stock Has Not Caught Up To Yet
TrefisIs Volunteering Good for Your Health? New Research From The Cigna Group Finds a Strong Connection
YahooIs Cigna Group (CI) Still Undervalued Or Are The Risks Keeping It Fairly Priced?
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Healthcare Plans Stocks
UnitedHealth Group Incorporated
$374.30B
CVSCVS Health Corporation
$119.52B
ELVElevance Health, Inc.
$94.15B
HUMHumana Inc.
$51.08B
CNCCentene Corporation
$34.16B
MOHMolina Healthcare, Inc.
$11.22B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
MRKMerck & Co., Inc.
$369.78B
NVSNovartis AG
$292.58B













